
1. Technology overview
Qlucore AB is a software company based at Ideon Science Park in Lund, Sweden, with an office in New York. It builds visualization-based software for omics data analysis in research and cancer diagnostics.
Qlucore Diagnostics is software for molecular diagnostics in clinical labs. It applies disease-specific machine-learning classifiers to RNA sequencing data from standard NGS workflows and returns genetic subtype probabilities in visual reports. Its first CE-marked product, Qlucore Diagnostics BCP-ALL 1.0, targets B-cell precursor acute lymphoblastic leukemia and is certified under IVDR. Tests for AML and bladder cancer are in development with EU funding. The company also sells Omics Explorer and Insights for research use.
2. Highlighted features & specifications
- Classifier models: AI-powered, disease-specific models based on gene expression.
- Plug-in architecture: multiple disease areas can be added to one platform.
- Gene fusion reporting: tier-based fusion detection and reporting.
- Visual reports: patient-friendly visualizations of subtype probabilities.
- NGS compatibility: works with RNA sequencing data from standard NGS workflows.
- Regulatory status: BCP-ALL 1.0 is IVDR certified; lung and bladder modules are research use only.
3. Potential application
Hematology and oncology labs at large Vietnamese hospitals could use it to subtype leukemia from RNA-seq data. Private genomics labs could use the research modules to analyze multi-omics datasets. Research institutes could use Omics Explorer for exploratory analysis.
4. Benefits
Lets clinical labs run molecular diagnostics on existing NGS workflows without specialized training. Visual, patient-friendly reports present subtype results. A plug-in architecture allows adding further disease areas over time. The BCP-ALL module is IVDR certified for clinical use in the EU.
5. Market trends & opportunities
RNA sequencing is moving into routine cancer diagnostics, and labs need regulated software to interpret the data. Vietnam's growing cancer genomics and NGS capacity at major hospitals and private labs creates a possible market, though the CE/IVDR status applies to the EU.
6. Other information
Qlucore AB, Ideon Science Park, Scheelevägen 17, Lund, Sweden, with an office in New York. EIC Accelerator grant of 27 MSEK awarded in 2024. Users cited include Yale School of Medicine, Stanford University and King's College London.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































